Major flares in women with SLE on combined oral contraception

Clinical Rheumatology

Volumn 26, Issue 12, 2007, Pages 2163-2165

  Whitelaw, D A ^a   Jessop, S J ^b  

^a STELLENBOSCH UNIVERSITY   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Flares; Oral contraceptives; Systemic lupus erythematosus

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; CREATINE KINASE; CYCLOPHOSPHAMIDE; ESTROGEN; ETHINYLESTRADIOL PLUS LEVONORGESTREL; METHOTREXATE; METHYLPREDNISOLONE; ORAL CONTRACEPTIVE AGENT; PREDNISONE;

ADULT; ARTHRITIS; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DISEASE ACTIVITY; DISEASE CONTROL; DISEASE SEVERITY; DRUG PULSE THERAPY; DRUG RESPONSE; DRUG WITHDRAWAL; DYSPNEA; ECHOCARDIOGRAPHY; FATALITY; FEMALE; FEVER; FOLLOW UP; HUMAN; KIDNEY BIOPSY; LEUKOCYTOSIS; LOW DRUG DOSE; LUNG INFILTRATE; MYOCARDITIS; MYOSITIS; NEPHRITIS; OPEN STUDY; ORAL CONTRACEPTION; PATIENT MONITORING; PERICARDIAL EFFUSION; PREMENOPAUSE; PRIORITY JOURNAL; RELAPSE; SEPSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; THORAX PAIN; URINE SEDIMENT; VASCULITIC RASH; WEAKNESS;

ADULT; CONTRACEPTIVES, ORAL; FEMALE; FOLLOW-UP STUDIES; HOT FLASHES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 36249002289     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-007-0641-y     Document Type: Article

References (15)

1. Petri M, Kim MY, Kalunian KC et al (2005) Combined oral contraception in women with systemic lupus erythematosus. N Engl J Med 353:2550-2558
2. Sanchez-Guerrero J, Uribe AG, Jimenez-Santana L et al (2005) A trial of contraceptive methods in women with systemic lupus erythematosus. N Engl J Med 353:2539-2549
3. Bermas BL (2005) Oral contraceptives in systemic lupus erythematosus - a tough pill to swallow? N Engl J Med 353:2602-2604
4. Cooper GS, Parks CG, Treadwell EL et al (2002) Differences by race, sex and age in the clinical and immunologic features of recently diagnosed systemic lupus erythematosus patients in the southeastern United States. Lupus 11:161-167
5. Alarcon GS, McGwin G Jr, Petri M et al (2002) Baseline characteristics of a multiethnic lupus cohort: PROFILE. Lupus 11:95-101
6. Bombardier C, Gladman DD, Urowitz MB et al (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35:630-640
7. Austin HA 3rd, Klippel JH, Balow JE et al (1986) Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs. N Engl J Med 314:614-619
8. Ehrenstein MR, Conroy SE, Heath J et al (1995) The occurrence, nature and distribution of flares in a cohort of patients with systemic lupus erythematosus: A rheumatological view. Br J Rheumatol 34:257-260
9. Petri M, Genovese M, Engle E et al (1991) Definition, incidence and clinical description of flare in systemic lupus erythematosus. A prospective cohort study. Arthritis Rheum 34:937-944
10. Rampone A, Rampone B, Tirabasso S et al (2001) Contraception with the latest estroprostagens in women suffering from systemic lupus erythematosus. Minerva Ginecol 53(1 Suppl 1):75-77
11. Julkunen HA (1991) Oral contraception in systemic lupus erythematosus: side-effects and influence on the activity of SLE. Scand J Rheum 20:427-433
12. Jungers P, Dougados M, Pelissier C et al (1982) Influence of oral contraceptive therapy on the activity of systemic lupus erythematosus. Arthritis Rheum 25:618-623
13. Buyon JP, Petri MA, Kim MY et al (2005) The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: A randomized trial. Ann Intern Med 142:953-962
14. Grimaldi CM, Hill L, Xu X et al (2005) Hormonal modulation of B cell development and repertoire selection. Mol Immunol 42:811-820
15. Cutolo M (2004) Estrogen metabolites: Increasing evidence for their role in rheumatoid arthritis and systemic lupus erythematosus. J Rheumatol 31:419-421